Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Veracyte, Inc.

A Comparative Analysis of SG&A Expenses: Walgreens Boots Alliance vs. Veracyte

In the ever-evolving landscape of corporate finance, understanding operational costs is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two distinct companies: Walgreens Boots Alliance, Inc. and Veracyte, Inc., from 2014 to 2023.

Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance, a global leader in retail and wholesale pharmacy, has consistently maintained high SG&A expenses, peaking at approximately $28 billion in 2024. This represents a steady increase of around 44% from 2014, reflecting its expansive operations and strategic investments.

Veracyte, Inc.

In contrast, Veracyte, a genomic diagnostics company, shows a different trajectory. Its SG&A expenses grew by over 350% from 2014 to 2023, highlighting its rapid expansion and increased market presence.

This comparison underscores the diverse financial strategies and growth patterns of these companies, offering valuable insights into their operational efficiencies and market dynamics.